This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)
C3_RENAL_CELL_CARCINOMA_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1265 |
4. Check minimum number of eventsNone |
1265 |
5. Include endpointsNone |
1265 |
6. Filter based on genotype QC (FinnGen only) |
1265 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Renal cell carcinoma of kidney
- Malignant neoplasm of kidney, except renal pelvis
- Malignant neoplasm of urinary organs
- Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1265 | 474 | 791 |
| Unadjusted period prevalence (%) | 0.28 | 0.16 | 0.35 |
| Median age at first event (years) | 63.23 | 60.73 | 64.72 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1176
- Matched controls
- 11771
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
323.0
413
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
323.0
1012
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
323.0
1021
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
323.0
334
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
227.2
323.0
574
49
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
310
*
8317/3-C64.9
ICD-O-3
Renal cell carcinoma, chromophobe type of kidney, NOS
+∞
161.2
151
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
339.8
149.3
148
5
7125
FHL
Nephrectomy (extrrafascial)
+∞
147.0
138
*
197
Kela drug reimbursment
Sunitinib
+∞
122.0
115
*
JN4AD
NOMESCO Finland
Body CT examination
13.4
115.9
212
190
KAC00
NOMESCO Finland
Nephrectomy
603.1
112.9
110
*
JN4BD
NOMESCO Finland
Extensive body CT
10.1
111.3
237
287
L01XE04
ATC
[U] sunitinib; oral
+∞
111.2
105
*
C64.80
ICD-10 Finland
Wilms tumour
+∞
110.1
104
*
KAD00
NOMESCO Finland
Partial nephrectomy
578.8
108.6
106
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
154.4
107.1
112
8
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
+∞
106.9
101
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
104.8
99
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
104.8
99
*
180
Kela drug reimbursment
Interferon alfa
+∞
100.5
95
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.5
86.1
288
653
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
437.0
83.0
82
*
H02AB02
ATC
dexamethasone; systemic
25.9
81.6
115
49
JN4CD
NOMESCO Finland
Very extensive body CT
19.2
76.0
118
68
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
75.8
72
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
73.7
70
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
69.4
66
*
U75
ICPC
Malignant neoplasm of kidney
673.8
65.5
64
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
63.1
60
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.4
61.9
256
703
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
88.7
60.6
67
8
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.4
59.4
110
97
B01AB10
ATC
tinzaparin; parenteral
7.4
57.2
144
218
1502
Kela drug reimbursment
Cabozantinib
+∞
56.7
54
*
116
Kela drug reimbursment
Prostate cancer
+∞
56.7
54
*
3012
Kela drug reimbursment
Cabozantinib
+∞
55.6
53
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
22.8
54.3
79
37
1890X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]
+∞
53.5
51
*
C648
ICD-10 Finland
NA
+∞
52.5
50
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
141.3
51.2
54
*
N02AX02
ATC
tramadol; systemic, rectal
2.6
50.0
585
3279
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
49.3
47
*
322
Kela drug reimbursment
Sunitinib
+∞
49.3
47
*
159
Kela drug reimbursment
Pazopanib
+∞
48.2
46
*
N02AA05
ATC
oxycodone; systemic
3.5
43.7
235
787
115
Kela drug reimbursment
Breast cancer
+∞
43.0
41
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
41.6
330
1443
158
Kela drug reimbursment
Everolimus
+∞
40.9
39
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
46.3
40.3
49
11
A04AA02
ATC
granisetron; systemic, transdermal
144.9
40.0
42
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
39.8
38
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
38.4
324
1458
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
37.7
36
*
L01XE26
ATC
[U] cabozantinib; oral
+∞
37.7
36
*
L01XE11
ATC
[U] pazopanib; oral
+∞
37.7
36
*
B01AB05
ATC
enoxaparin; parenteral
2.5
37.5
392
1984
Z51.5
ICD-10 Finland
Palliative care
7.4
37.2
91
131
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
367.9
36.2
36
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.2
35.8
100
173
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
27.7
35.2
48
18
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
34.5
165
499
L03AA04
ATC
NA
346.6
34.1
34
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
76.4
33.0
37
5
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
174.8
32.9
34
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.2
32.0
104
216
KA1AE
NOMESCO Finland
Kidney ultrasound examination
8.5
31.9
71
88
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
31.4
30
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
31.4
30
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
31.4
30
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.7
31.3
82
130
XX3DW
NOMESCO Finland
Time consuming IT work
4.8
30.7
108
244
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.8
29.2
85
155
R31
ICD-10 Finland
Unspecified haematuria
3.0
28.9
188
707
L03AB05
ATC
interferon alfa-2b; parenteral
106.0
28.8
31
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
28.2
27
*
L01EX07
ATC
cabozantinib; oral
+∞
28.2
27
*
WZC30
NOMESCO Finland
Teaching
3.3
28.0
154
514
L02AE02
ATC
leuprorelin; implant, parenteral
54.7
27.3
32
6
L01BC06
ATC
capecitabine; oral
+∞
27.2
26
*
UKC02
NOMESCO Finland
Cystoscopy
2.5
27.0
252
1172
A04AA01
ATC
ondansetron; systemic, rectal
9.1
26.4
56
64
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
26.1
25
*
18900
ICD-8 Finland
Malignant neoplasm of other and unspecified urinary organs, Kidney, except pelvis
+∞
26.1
25
*
KA3LT
NOMESCO Finland
Njurlesion coagulation
266.0
25.8
26
*
L03AB04
ATC
interferon alfa-2a; parenteral
266.0
25.8
26
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
266.0
25.8
26
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
25.1
535
3542
WF002
NOMESCO Finland
Radical radiotherapy
59.3
25.1
29
5
198
Kela drug reimbursment
Sorafenib
+∞
25.1
24
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
25.1
24
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
24.7
155
567
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
11.1
24.7
47
44
L02BG04
ATC
letrozole; oral
49.4
24.4
29
6
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
24.0
23
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.7
23.9
70
129
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
88.6
23.7
26
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
244.6
23.7
24
*
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
42.3
23.7
29
7
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
23.0
22
*
168
Kela drug reimbursment
Axitinib
+∞
23.0
22
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
23.0
22
*
A11CC03
ATC
alfacalcidol; systemic
5.7
22.0
64
117
L01XE10
ATC
[U] everolimus; oral
+∞
21.9
21
*
L02BB03
ATC
bicalutamide; oral
223.8
21.7
22
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
21.2
140
528
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
20.9
20
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
213.5
20.6
21
*
SPAT1153
SPAT
Removal of sutures
1.9
19.1
362
2238
M04AA01
ATC
allopurinol; systemic
2.1
18.3
225
1172
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.5
18.3
43
59
XKD00
NOMESCO Finland
Uroflowmetry
2.1
18.1
230
1213
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
18.0
109
389
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
17.7
17
*
M05BA02
ATC
clodronic acid; systemic
+∞
17.7
17
*
Y77
ICPC
Malignant neoplasm prostate
+∞
17.7
17
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
17.7
17
*
L01XE05
ATC
[U] sorafenib; oral
+∞
17.7
17
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
17.7
17
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
17.7
17
*
L02BA01
ATC
tamoxifen; oral
+∞
17.7
17
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
17.7
17
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
17.7
17
*
L03AA13
ATC
pegfilgrastim; parenteral
182.5
17.6
18
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
182.5
17.6
18
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
17.5
94
309
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.3
17.2
41
58
HAB40
NOMESCO Finland
Wedge excision of mammary gland
22.2
16.9
24
11
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.0
16.7
68
178
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.8
16.7
42
64
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
16.7
16
*
L01XE17
ATC
[U] axitinib; oral
+∞
16.7
16
*
1890A
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]
+∞
16.7
16
*
340
Kela drug reimbursment
Everolimus
+∞
16.7
16
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
91.3
16.6
18
*
N18.8
ICD-10 Finland
Other chronic renal failure
3.9
16.5
68
180
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
172.2
16.5
17
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
16.5
363
2338
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.6
16.3
128
534
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
30.5
16.1
21
7
TK800
NOMESCO Finland
Hemodialysis
5.2
15.9
49
97
Z49.0
ICD-10 Finland
Preparatory care for dialysis
9.4
15.7
32
35
WW500
NOMESCO Finland
Blood transfusion
4.9
15.7
51
107
A12AA04
ATC
calcium carbonate; oral
5.8
15.7
44
78
A79
ICPC
Malignancy NOS
+∞
15.7
15
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
15.7
15
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
15.7
15
*
343
Kela drug reimbursment
Pazopanib
+∞
15.7
15
*
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
22.4
15.6
22
10
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
162.0
15.5
16
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
9.1
15.5
32
36
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.7
15.5
53
118
R50.9
ICD-10 Finland
Fever, unspecified
2.2
15.2
164
803
HA1AA
NOMESCO Finland
X-ray mammography
5.2
15.1
47
94
N02AA01
ATC
morphine; systemic, rectal
8.2
15.1
33
41
M05BX04
ATC
denosumab; parenteral
3.6
14.8
67
193
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
14.6
14
*
L03AA02
ATC
filgrastim; parenteral
81.1
14.6
16
*
U14
ICPC
Kidney symptom/complaint
6.5
14.5
37
58
JN6AD
NOMESCO Finland
CT of torso and neck
36.5
14.5
18
5
ZXC96
NOMESCO Finland
Robot assisted procedure
15.6
14.4
23
15
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
14.4
169
856
J01MA02
ATC
ciprofloxacin; systemic
1.7
14.4
457
3254
C08CA01
ATC
amlodipine; oral
1.6
13.9
475
3439
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.4
13.8
32
44
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
14.9
13.6
22
15
205
Kela drug reimbursment
Chronic hypertension
1.6
13.6
441
3147
C50.99
ICD-10 Finland
Breast, unspecified
+∞
13.6
13
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
13.6
13
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
13.6
13
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
13.6
13
*
361
Kela drug reimbursment
Axitinib
+∞
13.6
13
*
B02AA02
ATC
tranexamic acid; systemic
2.3
13.5
129
594
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
141.5
13.5
14
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.6
13.4
34
53
Z31.5
ICD-10 Finland
Genetic counselling
5.8
13.4
37
65
GD1AD
NOMESCO Finland
Thorax CT examination
3.6
13.3
59
168
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.2
13.3
50
123
N18.0
ICD-10 Finland
End-stage renal disease
6.2
12.9
34
56
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
12.5
12
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
12.5
12
*
L01EX01
ATC
sunitinib; oral
+∞
12.5
12
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
12.5
12
*
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
12.5
12
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
12.5
12
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
12.5
12
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
12.5
12
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
12.5
12
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
12.5
141
701
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
131.3
12.5
13
*
137
Kela drug reimbursment
Uraemia requiring dialysis
9.8
12.3
24
25
KCD02
NOMESCO Finland
Transurethral resection of bladder
10.2
12.0
23
23
V03AE01
ATC
polystyrene sulfonate; oral
5.3
11.7
35
68
UJF32
NOMESCO Finland
Coloscopy
1.7
11.6
273
1768
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
11.5
11
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
11.5
11
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
11.5
11
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
11.5
11
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
11.5
11
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
11.5
11
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
121.1
11.4
12
*
7124
FHL
Nephrectomy (simple
121.1
11.4
12
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.9
11.3
20
17
S18
ICPC
Laceration/cut
1.6
11.3
417
3042
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.1
11.3
43
108
B03XA02
ATC
darbepoetin alfa; parenteral
5.0
11.2
35
72
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
11.1
70
257
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
6.2
11.1
29
48
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
11.0
89
375
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
7.5
11.0
25
34
J01MA12
ATC
levofloxacin; systemic
1.8
10.9
209
1264
ZX120
NOMESCO Finland
Intravenous
2.4
10.9
95
419
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
43.7
10.9
13
*
C03CA01
ATC
furosemide; systemic
1.5
10.8
458
3441
N02BE01
ATC
paracetamol; systemic, rectal
1.6
10.7
912
8027
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
60.5
10.6
12
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
60.5
10.6
12
*
RD211
NOMESCO Finland
NA
3.3
10.6
53
167
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
110.9
10.4
11
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
10.4
10
*
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
+∞
10.4
10
*
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
+∞
10.4
10
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
10.4
10
*
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
10.4
10
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
10.4
10
*
V03AE02
ATC
sevelamer; oral
16.2
10.4
16
10
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.0
10.1
27
46
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.8
10.0
63
232
Z90.5
ICD-10 Finland
Acquired absence of kidney
55.4
9.7
11
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.9
9.6
23
34
B05DA
ATC
Isotonic solutions
10.1
9.5
18
18
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
15.2
9.5
15
10
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
9.5
334
2382
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.1
9.5
50
165
JLC10
NOMESCO Finland
Distal pancreatectomy
100.8
9.4
10
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
9.4
9
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
9.4
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
9.4
9
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
9.4
9
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
9.4
9
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
+∞
9.4
9
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
9.4
9
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.2
9.4
48
155
JAH00
NOMESCO Finland
Laparotomy
3.8
9.4
38
102
C02AC05
ATC
moxonidine; oral
2.5
9.4
71
293
ZXA05
NOMESCO Finland
Left side
1.6
9.3
298
2078
ZXA00
NOMESCO Finland
Right side
1.6
9.2
310
2188
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
18.7
8.9
13
7
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
8.9
85
394
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
8.9
220
1431
A02BC02
ATC
pantoprazole; systemic
1.4
8.8
655
5458
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.1
8.8
33
83
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
50.3
8.7
10
*
127
Kela drug reimbursment
Transplant complication
7.7
8.7
19
25
A06AD11
ATC
lactulose; oral
1.7
8.6
204
1310
JMA10
NOMESCO Finland
Transabdominal total splenectomy
27.7
8.5
11
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
27.7
8.5
11
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.4
8.5
73
321
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
90.6
8.4
9
*
B03XA01
ATC
erythropoietin; parenteral
6.8
8.4
20
30
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.3
8
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
M907, C6488
ICD-10 Finland
NA
+∞
8.3
8
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
8.3
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
8.3
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.3
8
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
8.3
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.3
8
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
8.3
8
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
8.3
8
*
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
+∞
8.3
8
*
E83.50
ICD-10 Finland
Hypercalcemia
5.9
8.3
22
38
Z49.2
ICD-10 Finland
Other dialysis
9.5
8.3
16
17
WX402
NOMESCO Finland
General anaesthesia
1.9
8.1
117
643
TK820
NOMESCO Finland
Peritoneal dialysis
17.3
8.1
12
7
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
9.0
8.0
16
18
Z94.0
ICD-10 Finland
Kidney transplant status
9.0
8.0
16
18
JFB46
NOMESCO Finland
Resection of sigmoid colon
5.9
8.0
21
36
R33
ICD-10 Finland
Retention of urine
1.9
8.0
114
624
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.6
7.9
26
58
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
7.8
55
219
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.9
7.8
30
78
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.8
7.8
31
83
GDC00
NOMESCO Finland
Lobectomy of lung
45.2
7.7
9
*
J01EA01
ATC
trimethoprim; systemic
1.5
7.7
255
1782
1530
FHL
Urethrocystoscopy
3.3
7.6
36
111
BCA30
NOMESCO Finland
Unilateral adrenalectomy
18.5
7.6
11
6
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.8
7.6
48
177
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
25.2
7.6
10
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
7.5
296
2155
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
80.5
7.4
8
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
80.5
7.4
8
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
80.5
7.4
8
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
80.5
7.4
8
*
ZX112
NOMESCO Finland
Subcutaneous
6.5
7.4
18
28
XJH00
NOMESCO Finland
Transanal ultrasonography
2.1
7.4
81
400
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
7.4
163
1027
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
10.9
7.3
13
12
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
7.3
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.3
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
7.3
7
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
7.3
7
*
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
+∞
7.3
7
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
7.3
7
*
L02BG03
ATC
anastrozole; oral
+∞
7.3
7
*
B05DB
ATC
Hypertonic solutions
9.4
7.3
14
15
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.9
7.3
28
73
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.8
7.2
28
74
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
6.6
7.1
17
26
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
4.1
7.1
26
65
A06AH03
ATC
naloxegol; oral
8.8
7.1
14
16
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
10.1
7.0
13
13
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
7.0
97
525
G04CA02
ATC
tamsulosin; oral
1.5
7.0
325
2441
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.3
6.8
60
269
N07BC02
ATC
methadone; systemic
40.3
6.8
8
*
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
40.3
6.8
8
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
6.8
47
185
7321
FHL
TU biopsy, coagulation or laser
16.8
6.7
10
6
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
5.2
6.6
19
37
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
10.1
6.5
12
12
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
5.7
6.5
17
30
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
6.4
695
6032
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
70.2
6.4
7
*
Q60.0
ICD-10 Finland
Renal agenesis, unilateral
70.2
6.4
7
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
14.4
6.4
10
7
306
Kela drug reimbursment
Erythropoietin and darbepoetin
14.4
6.4
10
7
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
14.4
6.4
10
7
C08CA13
ATC
lercanidipine; oral
1.6
6.4
161
1050
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.8
6.3
106
614
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
5.2
6.3
18
35
L02AE03
ATC
goserelin; implant
18.1
6.3
9
5
1891X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]
+∞
6.3
6
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
6.3
6
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.3
6
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
6.3
6
*
2230A
ICD-9 Finland
Benign neoplasm of kidney and other urinary organs, Kidney, except pelvis
+∞
6.3
6
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
+∞
6.3
6
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
6.3
6
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
6.3
6
*
L01EX03
ATC
pazopanib; oral
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
6.3
6
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
6.3
6
*
U79
ICPC
Neoplasm urinary tract unspecified
+∞
6.3
6
*
8316/3-C64.9
ICD-O-3
Cyst-associated renal cell carcinoma of kidney, NOS
+∞
6.3
6
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
6.3
6
*
8318/3-C64.9
ICD-O-3
Renal cell carcinoma, sarcomatoid of kidney, NOS
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
L02BG06
ATC
exemestane; oral
+∞
6.3
6
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.8
6.2
19
40
GDA20
NOMESCO Finland
Excision of lesion of lung
26.8
6.2
8
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
6.2
41
159
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
3.7
6.2
25
69
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
6.2
47
195
S15
ICPC
Foreign body in skin
2.2
6.2
59
277
JFB30
NOMESCO Finland
Right hemicolectomy
5.8
6.1
16
28
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
12.6
6.1
10
8
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
12.6
6.1
10
8
196
Kela drug reimbursment
Paricalcitol and cinacalcet
12.6
6.1
10
8
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
12.6
6.1
10
8
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.6
6.1
12
14
SPAT1109
SPAT
Analgesia with portable analgesic pump
8.6
6.1
12
14
321
Kela drug reimbursment
Paricalcitol and cinacalcet
8.6
6.1
12
14
L04AA06
ATC
mycophenolic acid; systemic
4.9
6.1
18
37
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
204
234
10.20
167.49
1.2
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
252
833
3.53
62.70
9.7
5.7
mmol/l
12.0
11.4
0.53
238
780
(3003458) Phosphate [Moles/volume] in Serum or Plasma
302
1253
2.85
50.06
8.6
4.3
mmol/l
1.1
1.0
4.30
277
1130
(40768804) Tissue Pathology biopsy report
474
2557
2.37
44.69
2.4
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
160
523
3.36
39.61
2.6
1.4
ug/l
7.3
3.5
0.76
130
397
(3002256) Pathology report gross observation
171
588
3.21
38.94
1.3
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
115
316
3.90
36.90
3.5
2.4
g/l
0.4
0.3
0.55
81
103
(3035637) Corticotropin [Mass/volume] in Plasma
46
61
7.79
32.85
1.6
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
538
3383
2.03
31.77
4.6
3.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
584
3823
1.98
30.35
4.8
3.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
185
769
2.65
29.43
5.5
3.5
ng/l
133.2
91.8
4.35
163
653
(3024561) Albumin [Mass/volume] in Serum or Plasma
593
3967
1.93
28.30
7.3
3.7
g/l
34.0
34.9
2.96
558
3605
(3044640) Blood type and Crossmatch panel - Blood
420
2537
1.98
26.76
2.8
2.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
616
4285
1.85
25.04
10.4
4.9
mmol/l
1.2
1.2
1.35
580
3755
(3000850) Epithelial cells [#/volume] in Urine
350
2027
2.00
24.85
3.2
2.5
e6/l
2.9
4.7
5.85
316
1765
(3016502) Oxygen saturation in Arterial blood
219
1062
2.28
24.65
6.1
6.4
%
96.0
95.0
1.41
213
1018
(3012095) Magnesium [Moles/volume] in Serum or Plasma
259
1348
2.16
24.48
4.3
2.5
mmol/l
0.8
0.8
1.32
247
1226
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
205
973
2.32
24.24
4.1
2.6
u/l
255.8
242.0
0.46
197
900
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
627
4442
1.82
23.50
10.6
3.7
umol/l
11.1
12.5
1.02
601
4142
(3000991) Gas panel - Venous blood
174
797
2.37
22.23
8.4
6.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
647
4712
1.76
21.34
12.6
5.3
mmol/l
1.2
1.2
0.26
556
3936
(3027801) Oxygen [Partial pressure] in Arterial blood
226
1189
2.10
20.47
6.0
6.2
kpa
12.8
11.3
4.24
218
1124
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
226
1189
2.10
20.47
6.0
6.2
kpa
5.1
5.1
0.31
219
1127
(3003396) Base excess in Arterial blood by calculation
225
1188
2.09
20.17
6.0
6.2
mmol/l
0.2
1.3
3.72
175
909
(3013650) Neutrophils [#/volume] in Blood by Automated count
635
4676
1.72
19.48
12.7
6.0
e9/l
4.3
4.5
1.29
569
3994
(3031040) Bacteria [#/volume] in Urine by Automated count
775
6071
1.71
18.56
6.2
4.7
e6/l
497.3
3253.7
1.42
18
115
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
320
1957
1.85
18.52
2.9
2.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
426
2843
1.75
18.36
4.3
3.2
e6/l
122.9
92.9
0.17
364
2209
(3018418) pH of Serum or Plasma
412
2727
1.76
18.25
7.7
3.1
ph
7.4
7.4
2.45
85
473
(3030467) Casts [#/volume] in Urine by Automated count
394
2576
1.77
18.21
4.0
3.1
e6/l
0.2
0.4
5.20
335
1970
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
153
735
2.23
17.32
3.9
2.5
ml/min/173m2
49.4
60.6
6.79
104
314
(3015377) Calcium [Moles/volume] in Serum or Plasma
436
2977
1.71
17.04
5.7
2.0
mmol/l
2.4
2.3
1.51
386
2417
(36304419) Bacteria [Presence] in Urine
377
2476
1.74
16.93
4.1
3.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
843
6843
1.70
16.84
13.3
5.3
u/l
80.9
77.6
1.48
805
6263
(3018095) Leukocytes [#/volume] in Urine
466
3261
1.68
16.49
5.0
3.6
e6/l
79.8
116.9
0.50
387
2356
(3009214) Lutropin [Units/volume] in Serum or Plasma
45
113
4.09
16.30
1.3
1.3
u/l
22.2
8.1
2.87
34
92
(40761535) Cells panel - Urine sediment
168
865
2.09
15.90
5.3
3.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
234
1375
1.86
15.06
4.2
2.4
g/l
2.1
2.3
6.46
218
1253
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
62
204
3.14
15.03
2.8
2.5
mg/l
1.9
1.7
0.49
56
177
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
221
1281
1.88
14.83
4.4
2.5
%
19.9
22.5
2.46
188
1070
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
58
185
3.24
14.80
2.5
1.7
u/ml
45202.6
79.0
0.51
50
146
(3032080) INR in Blood by Coagulation assay
550
4119
1.59
14.25
12.6
11.4
inr
1.2
1.4
3.56
147
1152
(3014111) Lactate [Moles/volume] in Serum or Plasma
158
839
2.01
13.68
6.2
5.6
mmol/l
1.1
1.5
7.32
152
800
(3036481) Cortisol [Moles/volume] in Serum or Plasma
145
748
2.06
13.59
4.8
1.7
nmol/l
407.8
361.4
2.06
138
667
(3023368) Bacteria identified in Blood by Culture
397
2778
1.63
13.46
5.1
4.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
246
1518
1.77
13.35
4.2
2.4
umol/l
10.3
12.6
6.59
228
1371
(3026782) Osmolality of Urine
290
1877
1.71
13.27
3.8
2.7
mosm/kgh2o
520.7
548.6
1.72
259
1572
(3019060) Gas panel - Arterial blood
142
735
2.05
13.18
4.4
4.6
—
—
—
0
0
(3020891) Body temperature
99
444
2.33
13.14
5.6
4.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
83
346
2.50
12.93
2.5
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
131
665
2.08
12.81
1.8
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
360
2501
1.61
12.39
4.0
2.5
umol/l
3612.0
7760.6
0.94
308
2094
(3008152) Bicarbonate [Moles/volume] in Arterial blood
136
713
2.02
12.17
6.9
6.7
mmol/l
24.3
24.5
0.23
131
665
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
398
2853
1.58
11.92
3.8
2.2
u/l
64.7
59.6
0.56
374
2606
(3029937) Albumin [Presence] in Urine by Test strip
354
2496
1.58
11.28
6.4
4.2
estimate
0.0
0.0
0.50
112
730
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
244
1570
1.69
11.23
3.3
2.7
e6/l
0.7
1.2
2.89
157
910
(3013826) Glucose [Moles/volume] in Serum or Plasma
679
5561
1.48
10.38
6.2
4.4
mmol/l
7.0
6.9
0.19
653
5214
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
114
3.31
10.04
4.4
5.8
iu/ml
85.0
468.7
—
5
13
(3037467) Urinalysis macro (dipstick) panel - Urine
750
6294
1.47
9.92
5.7
4.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
5
26.24
9.82
10.8
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
404
3010
1.50
9.76
3.5
3.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
454
3472
1.48
9.61
6.0
4.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
101
518
2.03
9.60
8.1
8.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
36
113
3.25
9.50
1.3
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
560
4478
1.45
9.33
7.2
5.1
estimate
0.0
0.0
0.00
120
762
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
42
148
2.90
9.13
5.1
2.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
565
4539
1.44
9.11
6.0
3.8
estimate
0.0
0.0
0.50
124
750
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
67
299
2.31
9.04
1.2
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
16
28
5.77
8.81
8.8
1.1
u/ml
59.8
34.4
—
5
5
(3035350) Ketones [Presence] in Urine by Test strip
556
4473
1.43
8.80
5.8
3.8
estimate
0.0
0.0
0.00
122
770
(3002032) Base excess in Venous blood by calculation
160
988
1.71
8.47
6.5
3.0
mmol/l
0.8
2.1
4.12
122
773
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
78
384
2.10
8.29
4.3
2.9
pmol/l
4.2
4.4
0.60
67
324
(3013115) Eosinophils [#/volume] in Blood
541
4366
1.42
8.25
6.1
5.3
e9/l
0.2
0.2
1.09
467
3753
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
94
498
1.96
8.17
7.6
7.7
mmol/l
23.1
24.3
3.77
87
446
(3019198) Lymphocytes [#/volume] in Blood
532
4294
1.41
8.05
6.3
5.2
e9/l
1.8
1.8
0.27
464
3706
(40760892) CBC W Ordered Manual Differential panel - Blood
242
1677
1.55
8.01
4.3
4.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
11
14
7.92
8.00
1.9
1.5
ng/l
136.9
86.0
0.52
11
14
(3006315) Basophils [#/volume] in Blood
524
4224
1.41
7.96
6.0
5.2
e9/l
0.0
0.0
0.09
458
3579
(3021447) Carbon dioxide [Partial pressure] in Venous blood
158
990
1.68
7.91
6.1
3.0
kpa
5.7
5.8
0.62
153
952
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
70
338
2.13
7.83
2.3
2.7
u/ml
0.4
0.4
0.09
37
207
(3001604) Monocytes [#/volume] in Blood
520
4200
1.40
7.75
6.0
5.1
e9/l
0.6
0.6
0.21
452
3548
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
20
48
4.22
7.75
1.3
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
276
1984
1.50
7.67
10.3
4.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
20
49
4.13
7.55
1.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
106
603
1.83
7.43
5.5
3.3
mmol/l
0.8
1.7
1.54
74
440
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
16
33
4.90
7.42
1.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
16
33
4.90
7.42
1.4
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
87
465
1.94
7.39
5.2
3.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
253
1799
1.51
7.38
5.4
2.2
mmol/l
2.5
2.4
7.87
225
1511
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
212
1455
1.55
7.29
3.7
2.9
e6/l
2.1
2.1
0.01
126
802
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
86
462
1.92
7.20
8.5
3.4
mmol/l
23.0
24.3
4.50
73
402
(3009343) pH of Capillary blood
108
626
1.79
7.13
5.6
3.4
ph
7.4
7.4
0.57
14
79
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
117
698
1.75
7.00
2.2
1.9
g/l
0.2
0.2
3.49
105
621
(3019150) Specific gravity of Urine by Refractometry
292
2159
1.46
6.98
6.6
4.2
kg/l
1.0
1.0
0.09
40
334
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
17
39
4.40
6.97
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
798
8891
0.72
6.90
6.0
5.0
mmol/l
6.1
6.1
0.09
721
7941
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
33
127
2.64
6.17
1.3
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
12
23
5.26
6.01
1.1
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
22
71
3.14
5.63
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
47
3.65
5.49
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
26
94
2.80
5.49
1.4
1.2
iu/l
57.9
29.4
2.45
18
82
(3018677) aPTT in Platelet poor plasma by Coagulation assay
209
1513
1.46
5.48
2.1
1.8
s
30.4
30.2
0.17
209
1459
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
822
9014
0.75
5.47
5.5
5.4
mmol/l
2.5
2.6
0.98
741
8154
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
186
1325
1.47
5.30
14.8
7.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
231
1716
1.42
5.27
1.8
1.8
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
29
114
2.58
5.23
1.4
1.5
e6/l
2125.1
1677.5
0.19
24
81
(3030981) Hyaline casts [#/volume] in Urine by Automated count
87
521
1.72
5.18
3.9
2.5
e6/l
0.2
0.3
0.31
87
508
(21494890) Protein electrophoresis panel - 24 hour Urine
24
87
2.79
5.06
1.5
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
98
618
1.63
4.82
2.2
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
9
10
9.05
4.78
10.2
5.6
mmol/l
4.8
6.3
—
9
10
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
38
177
2.18
4.75
1.3
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
351
2833
1.33
4.74
6.3
5.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
40
191
2.13
4.71
1.3
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
801
8753
0.77
4.70
5.1
4.8
mmol/l
4.4
4.4
0.52
727
7958
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
83
506
1.69
4.65
5.7
6.9
mmol/l
24.0
24.8
1.36
83
501
(4281824)
14
38
3.71
4.65
1.1
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
286
2245
1.35
4.64
6.2
3.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
124
836
1.54
4.60
2.8
1.6
g/l
65.7
66.8
0.70
115
739
(3012516) Albumin [Mass/volume] in Urine
386
3174
1.31
4.54
3.9
3.2
mg/l
409.7
171.3
0.65
267
2039
(3037756) Immunofixation for Serum or Plasma
41
202
2.06
4.47
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
70
412
1.74
4.46
1.3
1.2
iu/ml
126.0
130.0
0.03
19
167
(3009508) Creatinine [Moles/volume] in Urine
393
3246
1.31
4.46
3.8
3.1
mmol/l
6.9
7.4
1.18
327
2716
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
436
3655
1.29
4.42
2.6
2.2
nmol/l
81.2
78.3
1.24
393
3132
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
56
311
1.84
4.33
2.7
2.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
450
3797
1.29
4.31
6.4
5.4
%
0.6
0.7
0.44
428
3476
(3000570) Elastase.pancreatic [Mass/mass] in Stool
43
219
2.00
4.30
1.4
1.4
ug/g
238.6
284.9
0.74
25
127
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
79
487
1.66
4.27
3.9
2.3
%
0.6
0.7
0.04
79
466
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
31
3.90
4.26
1.7
2.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
36
3.64
4.21
2.0
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
15
46
3.29
4.19
1.1
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
795
8650
0.78
4.18
5.0
4.7
mmol/l
1.4
1.4
4.61
719
7799
(40768806) Pleura Pathology biopsy report
22
85
2.62
4.15
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
36
175
2.09
4.08
1.7
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
25
104
2.43
4.07
2.4
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
92
599
1.58
4.01
2.2
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
469
4008
1.27
3.99
6.6
5.5
%
24.7
26.1
1.74
443
3647
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
75
465
1.65
3.98
1.7
1.6
g/l
1.8
1.5
1.57
62
391
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
93
2.50
3.98
5.6
2.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
461
3933
1.27
3.97
6.8
5.7
%
8.7
8.9
0.56
440
3607
(3020682) Albumin/Creatinine [Ratio] in Urine
401
3366
1.28
3.93
4.7
3.9
mg/mmol
25.9
8.2
4.16
274
2161
(3012441) Differential panel - Pleural fluid
23
94
2.47
3.89
1.4
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
458
3917
1.27
3.83
6.4
5.4
%
3.1
2.9
0.45
436
3576
(40760888) Immunoglobulin light chains.free panel - Serum
44
238
1.88
3.73
1.8
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
84
2.53
3.72
1.8
2.2
—
477.2
—
0
10
(3028308) Erythrocytes [#/volume] in Pleural fluid
24
103
2.36
3.68
1.4
1.5
e6/l
184771.5
87571.2
0.29
17
61
(3033658) Prothrombin time (PT) actual/Normal
262
2099
1.31
3.64
4.8
3.5
%
89.1
81.9
4.02
256
2031
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
135
975
1.43
3.59
3.8
3.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
230
1812
1.33
3.59
1.6
1.6
mg/l
1.3
1.4
0.15
175
1414
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
164
1227
1.39
3.57
1.7
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
38
199
1.94
3.56
4.1
2.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
6
10.04
3.50
1.0
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
107
743
1.48
3.50
7.5
2.7
mmol/l
1.2
1.2
0.46
99
618
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
25
112
2.26
3.49
2.4
1.3
nmol/l
0.6
0.7
0.46
25
105
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
119
2.21
3.46
1.5
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
311
2567
1.28
3.43
3.7
2.5
u/l
34.7
34.7
0.00
295
2428
(3041096) Erythrocytes [Presence] in Urine by Automated
280
2282
1.29
3.41
4.8
3.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
321
1.71
3.39
2.4
1.4
mg/l
65.7
48.4
0.96
46
255
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
54
321
1.71
3.39
2.4
1.4
mg/l
50.4
38.0
0.63
46
256
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
114
2.22
3.36
1.3
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
311
2573
1.28
3.36
2.4
2.2
mg/l
3.6
3.0
3.61
263
2151
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
123
887
1.43
3.31
3.1
2.3
umol/l
9.8
9.0
0.14
107
763
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
65
2.64
3.31
1.2
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
65
2.64
3.31
1.2
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
65
2.64
3.31
1.2
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
103
720
1.47
3.27
2.0
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
920
9746
0.79
3.22
39.5
21.4
e9/l
7.1
6.9
1.89
891
9339
(3000963) Hemoglobin [Mass/volume] in Blood
920
9746
0.79
3.22
39.6
21.5
g/l
130.0
134.7
14.39
903
9504
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
796
8565
0.81
3.22
7.7
6.5
mmol/mol
41.8
41.1
1.08
732
7814
(3026361) Erythrocytes [#/volume] in Blood
920
9744
0.79
3.20
39.5
21.3
e12/l
4.4
4.4
4.79
892
9333
(3024731) MCV [Entitic volume]
920
9743
0.80
3.19
39.2
21.3
fl
91.4
91.7
1.40
901
9500
(3035941) MCH [Entitic mass]
920
9743
0.80
3.19
39.2
21.2
pg
30.1
30.5
6.72
901
9502
(3018010) Neutrophils/100 leukocytes in Blood
457
3973
1.24
3.18
6.3
5.4
%
59.6
58.6
0.88
435
3641
(3007461) Platelets [#/volume] in Blood
920
9741
0.80
3.16
39.4
21.3
e9/l
239.3
239.0
0.03
894
9379
(3017181) Myelocytes/100 leukocytes in Blood
95
658
1.48
3.16
4.0
3.7
%
0.9
0.9
0.00
33
159
(3001122) Ferritin [Mass/volume] in Serum or Plasma
417
3593
1.24
3.14
3.7
2.7
ug/l
233.8
144.9
5.02
373
3245
(3009542) Hematocrit [Volume Fraction] of Blood
700
7620
0.82
3.11
25.1
16.3
%
37.8
39.0
1.79
412
4697
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
22
99
2.24
3.07
2.4
1.3
nmol/l
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
8
7.53
3.05
1.8
5.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
18
74
2.45
3.05
1.4
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
661
7229
0.82
3.05
35.3
19.6
g/l
329.7
332.0
7.77
650
7139
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
93
2.28
3.04
2.0
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
76
508
1.53
3.01
5.4
3.2
%
52.6
47.5
0.95
76
501
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
90
624
1.48
2.99
1.6
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
75
2.42
2.97
2.9
3.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
90
625
1.47
2.97
4.1
3.8
%
0.2
0.1
1.03
31
142
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
94
2.25
2.97
2.0
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
162
1.94
2.96
1.2
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
208
2570
0.77
2.94
3.2
3.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
58
367
1.61
2.91
2.0
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
95
2.23
2.91
1.3
1.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
95
2.23
2.91
2.0
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
160
1234
1.34
2.89
1.7
1.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
22
102
2.18
2.88
1.3
1.2
u/ml
112.8
108.2
—
6
13
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
96
2.21
2.84
2.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
46
277
1.69
2.80
3.0
3.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
728
6687
1.21
2.80
5.1
4.1
mm/h
18.4
13.6
7.37
668
6086
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
97
2.18
2.78
2.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
97
2.18
2.78
2.0
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
85
593
1.46
2.76
4.0
3.7
%
0.8
0.6
0.23
22
111
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
780
8358
0.83
2.75
4.6
4.2
mmol/l
1.5
1.3
8.94
699
7467
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
101
729
1.42
2.74
2.6
2.0
u/l
165.5
31.7
0.51
88
595
(3007853) Bacteria identified in Skin by Aerobe culture
138
1050
1.35
2.73
1.9
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
102
738
1.42
2.73
2.2
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
105
2.11
2.69
1.3
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
135
1.95
2.56
1.3
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
75
519
1.47
2.56
2.5
2.2
nmol/l
11.8
14.8
1.40
64
450
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
44
2.74
2.55
2.0
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
55
356
1.57
2.55
1.3
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
143
1107
1.33
2.54
3.0
2.6
ug/l
4.2
7.4
5.13
124
949
(3025159) Blasts/100 leukocytes in Blood
83
587
1.44
2.53
4.3
3.9
%
0.4
0.8
0.20
26
122
(3042631) Mycobacterium sp identified in Specimen
23
115
2.02
2.52
3.0
2.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
69
2.34
2.49
1.5
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
42
256
1.66
2.48
1.2
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
109
2.04
2.47
1.2
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
60
400
1.52
2.45
1.4
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
164
1302
1.30
2.43
2.0
2.0
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
6
12
5.02
2.40
1.2
1.0
u/l
4280.8
22.9
—
6
7
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
90
2.13
2.39
1.3
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
71
2.27
2.35
1.4
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
35
207
1.71
2.32
3.9
2.6
%
16.9
16.3
0.54
21
102
(1616796) Gas panel - Central venous blood
35
208
1.70
2.28
5.4
3.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
24
127
1.91
2.27
1.1
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
120
922
1.33
2.26
3.0
2.2
e9/l
63.9
67.7
0.77
95
719
(40768795) Lymph node Pathology biopsy report
7
18
3.90
2.25
1.0
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
58
394
1.49
2.20
2.1
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
361
0.52
2.19
1.3
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
42
2.63
2.19
2.0
2.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23
122
1.90
2.17
1.3
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
38
235
1.64
2.15
1.6
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
422
3754
1.19
2.15
12.8
8.8
e9/l
0.0
0.0
0.95
346
3031
(4133840)
7
19
3.70
2.15
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
41
259
1.60
2.14
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
198
2371
0.80
2.11
1.7
1.6
mmol/l
1.6
1.3
2.32
167
1942
(3006184) Hemoglobin [Mass/volume] in Capillary blood
37
229
1.63
2.10
3.5
2.2
g/l
127.9
131.7
0.44
27
172
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
23
124
1.87
2.08
2.7
2.6
mg/l
13.0
23.4
—
6
24
(3019225) pH of Specimen
124
970
1.31
2.07
10.7
3.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
41
262
1.58
2.05
1.2
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
28
162
1.74
2.03
1.6
1.8
iu/l
2.9
4.3
—
10
59
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
11
4.56
1.94
1.2
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
16
3.76
1.93
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
22
120
1.85
1.93
1.7
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
106
821
1.32
1.92
1.3
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
39
251
1.57
1.91
2.1
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
35
220
1.61
1.89
3.5
2.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
86
1.99
1.85
1.1
1.2
u/ml
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
12
4.18
1.82
1.4
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
35
2.58
1.80
2.6
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
74
551
1.36
1.76
4.3
3.3
e9/l
4.1
4.3
0.26
59
389
(3045788) Cell count panel - Pleural fluid
18
95
1.91
1.76
1.5
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
41
2.45
1.75
1.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
151
1241
1.25
1.73
2.8
2.0
%
1.7
1.8
0.21
136
1072
(40768441) Liver Pathology biopsy report
8
30
2.68
1.72
1.5
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
54
383
1.43
1.70
2.7
2.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
12
55
2.19
1.67
2.2
1.5
u/field
1.2
2.9
—
5
45
(3012501) Base excess in Blood by calculation
34
220
1.56
1.66
5.6
4.3
mmol/l
2.7
3.0
0.29
23
143
(44790048)
17
90
1.90
1.65
1.3
1.4
—
—
—
0
0
(44806118)
17
90
1.90
1.65
1.3
1.4
—
—
—
0
0
(44790049)
17
90
1.90
1.65
1.3
1.4
—
—
—
0
0
(44790047)
17
90
1.90
1.65
1.3
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
903
9406
0.86
1.63
16.5
9.3
u/l
30.1
24.9
0.48
865
8930
(3027315) Oxygen [Partial pressure] in Blood
34
222
1.55
1.61
5.6
4.3
kpa
8.9
8.2
1.14
34
217
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
20
3.01
1.58
1.2
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
776
8161
0.87
1.57
7.1
4.5
mu/l
2.1
2.2
0.18
711
7274
(3051651) Icteric interference index of Serum or Plasma
10
44
2.28
1.53
2.6
3.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
44
2.28
1.53
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
0
42
0.00
1.52
0.0
1.3
—
4.1
—
0
9
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
28
430
0.64
1.52
2.4
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
42
292
1.45
1.50
2.5
2.2
ug/min
242.7
79.4
1.22
28
171
(3003694) ABO and Rh group [Type] in Blood
228
1987
1.18
1.45
1.4
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
370
1.39
1.45
1.9
1.5
g/l
3.4
3.2
0.62
37
282
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
52
2.13
1.44
1.3
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
13
66
1.98
1.43
1.3
1.7
—
1.3
—
0
5
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
22
2.74
1.43
1.5
2.0
—
—
—
0
0
(3000492) Spirometry study
50
677
0.73
1.41
1.5
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
46
331
1.40
1.38
1.9
1.5
g/l
1.5
0.5
0.74
41
276
(40768797) Stomach Pathology biopsy report
139
1167
1.21
1.34
1.3
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
47
2.14
1.34
3.6
3.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
43
2.10
1.30
1.3
1.4
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
18
2.78
1.28
1.6
1.2
%
30.8
30.5
—
5
13
(3026389) Candida sp identified in Specimen by Organism specific culture
18
107
1.69
1.26
1.7
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
338
1.37
1.25
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
290
0.62
1.24
1.8
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
918
9493
0.88
1.24
32.5
18.2
mmol/l
4.1
4.0
23.95
891
9176
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
25
2.41
1.24
1.7
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
36
2.23
1.24
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
442
4087
1.13
1.22
5.1
4.1
ng/l
56.6
74.2
0.45
368
3102
(3024471) HLA-A [Type]
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
401
1.34
1.20
1.9
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
401
1.34
1.20
1.9
1.5
g/l
7.5
7.5
0.00
37
286
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
401
1.34
1.20
1.9
1.5
g/l
3.8
3.9
0.07
36
279
(3017704) Immunofixation for Urine
13
71
1.84
1.19
1.2
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
16
94
1.71
1.17
3.9
2.1
u/field
0.6
2.0
—
5
38
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.4
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
20
2.51
1.15
1.4
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.4
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
111
0.45
1.13
1.2
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
58
1.90
1.12
1.3
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
918
9472
0.89
1.11
32.4
18.1
mmol/l
139.1
139.7
7.88
893
9174
(3051611) Lipemic interference index of Serum or Plasma
15
88
1.71
1.11
2.7
3.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
85
694
1.24
1.10
5.7
4.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
41
1.96
1.09
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
41
1.96
1.09
1.0
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
350
3212
1.12
1.08
2.2
2.2
u/l
147.2
261.7
2.30
328
2995
(3013512) EKG study
325
2970
1.13
1.08
5.0
4.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
25
169
1.49
1.07
2.0
1.2
u/l
57.7
21.2
0.49
18
147
(3021788) Differential panel - Synovial fluid
11
192
0.57
1.06
1.2
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
1.3
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
1.3
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
1.3
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
380
3510
1.12
1.05
3.6
3.1
ng/l
2868.6
1839.1
2.18
343
3034
(3002385) Erythrocyte distribution width [Ratio]
671
7028
0.90
1.04
29.3
17.5
%
14.2
13.8
7.89
652
6811
(44813793)
9
46
1.96
1.03
1.1
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
34
2.06
1.03
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
164
1.47
0.99
1.4
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
22
320
0.68
0.99
1.1
1.1
—
165.8
—
0
8
(3000494) Fungus identified in Specimen by Culture
114
972
1.19
0.98
1.5
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
23
2.18
0.98
1.8
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
23
2.18
0.98
1.2
1.9
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
62
1.78
0.94
2.0
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
316
0.69
0.94
1.1
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
33
243
1.37
0.93
1.2
1.3
—
20.7
—
0
7
(3051387) C reactive protein [Mass/volume] in Capillary blood
31
226
1.38
0.93
4.4
3.3
mg/l
24.3
28.5
0.23
15
151
(1175426) CD3 cells/100 lymphocytes in Blood
6
28
2.15
0.91
1.5
1.8
%
77.8
74.9
—
6
23
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
141
1604
0.86
0.90
1.2
1.2
u/ml
0.7
2.0
2.86
35
430
(3005322) IgE [Units/volume] in Serum or Plasma
56
450
1.26
0.87
1.3
1.2
u/ml
119.3
244.2
2.54
45
407
(3047181) Lactate [Moles/volume] in Blood
44
343
1.29
0.87
5.7
5.6
mmol/l
1.2
1.3
0.26
37
309
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
44
1.82
0.86
1.4
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
45
1.78
0.84
1.5
2.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
57
1.76
0.83
2.0
1.7
—
—
—
0
0
(3036489) Thrombin time
35
266
1.32
0.83
1.5
1.9
s
25.0
21.1
0.98
30
239
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
70
837
0.83
0.81
1.3
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
114
1.50
0.79
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
33
1.82
0.79
1.3
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.4
—
166.9
—
0
19
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
78
659
1.20
0.78
1.8
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
122
1385
0.87
0.77
1.3
1.2
g/l
2.4
2.8
1.82
70
777
(3044941) Cell count panel - Synovial fluid
11
174
0.63
0.77
1.3
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
378
1.25
0.75
2.0
1.5
g/l
10.2
10.7
0.34
38
310
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
141
1.43
0.75
4.0
3.0
%
58.9
59.8
0.09
20
141
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
32
245
1.31
0.74
1.5
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
184
1.37
0.74
1.4
1.6
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
26
1.93
0.70
1.2
3.9
mu/l
17.1
19.5
—
5
21
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
410
4324
0.92
0.67
2.1
2.1
pmol/l
94.0
92.2
0.32
217
2229
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
28
1.79
0.66
1.0
1.1
miu/ml
909.2
1743.9
—
5
28
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
139
1.37
0.60
2.9
2.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
52
1.54
0.59
1.4
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
22
0.00
0.59
0.0
1.9
—
1.2
—
0
22
(3022806) Fractional oxyhemoglobin in Capillary blood
18
131
1.38
0.59
2.0
1.9
%
89.5
89.6
0.04
18
131
(3023419) Bacteria identified in Sputum by Culture
19
140
1.36
0.58
3.2
2.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
35
1.72
0.57
1.5
1.6
ug/l
6.4
12.9
—
6
30
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
54
1.48
0.57
1.0
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
539
5183
1.07
0.57
3.4
3.0
u/l
55.6
51.0
0.69
484
4691
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
149
0.67
0.56
1.1
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
36
1.67
0.56
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
891
9099
0.93
0.56
25.6
14.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
5
86
0.58
0.56
1.0
1.3
%
15.9
25.3
—
5
57
(3023183) Ammonium ion [Moles/volume] in Plasma
25
194
1.29
0.56
1.5
2.7
umol/l
25.6
35.4
3.58
17
164
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
53
449
1.19
0.56
4.8
4.3
%
1.6
1.7
0.74
48
427
(3005719) IgG [Mass/volume] in Serum or Plasma
63
543
1.17
0.55
2.9
2.0
g/l
10.3
10.9
0.56
52
490
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
65
749
0.86
0.54
1.7
1.7
%
1.5
1.6
0.68
55
619
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
30
241
1.25
0.52
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
30
241
1.25
0.52
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
143
1.33
0.52
1.1
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
19
143
1.33
0.52
2.9
2.2
mmol/l
106.2
105.3
0.44
19
143
(3041354) Potassium [Moles/volume] in Venous blood
19
143
1.33
0.52
2.9
2.2
mmol/l
4.3
4.1
1.04
19
143
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
807
8257
0.94
0.51
25.7
13.7
ml/min/173m2
59.6
72.9
49.49
724
6633
(40757494) Bilirubin.total [Moles/volume] in Blood
9
64
1.41
0.51
3.7
1.6
—
12.5
—
0
5
(3003327) Ova and parasites identified in Stool by Light microscopy
26
206
1.27
0.51
2.2
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
118
1.36
0.50
1.3
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
41
1.47
0.50
1.3
2.0
nmol/l
18.2
17.9
—
6
33
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
41
1.47
0.50
1.0
1.3
u/l
177.7
451.0
—
6
36
(3037522) Nuclear Ab [Titer] in Serum
114
1032
1.12
0.50
1.3
1.3
titre
705.5
589.8
0.14
22
250
(3045142) Bone marrow Pathology biopsy report
10
67
1.50
0.49
1.3
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
225
1.25
0.49
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
18
235
0.76
0.49
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
218
2328
0.92
0.49
3.2
2.7
ug/l
0.9
0.8
0.52
167
1627
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
7
109
0.64
0.48
1.0
1.1
—
86.2
—
0
21
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
267
0.78
0.48
1.8
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
166
0.72
0.48
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
48
1.46
0.47
2.9
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
48
1.46
0.47
2.9
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
83
0.60
0.45
1.2
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
50
574
0.87
0.43
1.2
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.4
1.0
—
—
—
0
0
(4015189)
5
33
1.52
0.41
4.2
2.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
436
4203
1.06
0.41
2.4
2.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
327
3418
0.94
0.41
4.8
3.9
%
23.1
24.2
0.59
184
1712
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
1.1
—
86.8
—
0
8
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
1.1
—
78.5
—
0
8
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
3.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
7
102
0.68
0.39
1.3
1.6
g/l
0.6
1.1
—
7
80
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
198
2101
0.93
0.39
4.7
4.2
ng/l
258.8
445.7
1.04
169
1802
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
124
1.29
0.38
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
47
536
0.87
0.38
1.4
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
68
1.33
0.37
1.0
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
100
1088
0.91
0.37
3.1
3.2
ng/l
348.2
273.6
0.62
93
1010
(3023410) Appearance of Cerebral spinal fluid
5
79
0.63
0.35
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
39
339
1.16
0.34
1.2
1.2
—
—
—
0
0
(4034850)
31
361
0.86
0.34
18.0
11.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
37
321
1.16
0.34
2.0
1.5
g/l
34.8
37.0
1.05
32
261
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
275
0.83
0.33
1.3
1.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
137
1.24
0.32
1.5
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
137
1290
1.07
0.29
1.2
1.2
u/ml
13.6
14.4
0.05
61
477
(3022217) INR in Platelet poor plasma by Coagulation assay
173
1642
1.06
0.29
30.4
30.4
inr
1.6
1.5
0.31
19
229
(3044889) 12 lead EKG panel
668
6553
1.04
0.29
5.2
4.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
111
0.72
0.28
1.3
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
66
719
0.91
0.27
1.3
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
116
0.77
0.27
1.1
1.2
—
—
—
0
0
(4146454)
9
121
0.74
0.27
2.1
2.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
66
1.21
0.26
1.8
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
27
234
1.16
0.26
1.7
1.6
iu/ml
0.3
0.1
—
9
54
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
67
1.20
0.26
1.1
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
71
0.70
0.26
1.4
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
73
0.68
0.26
11.8
13.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
896
8856
1.04
0.25
25.2
14.8
mg/l
32.2
26.1
4.79
797
7028
(3022621) pH of Urine by Test strip
71
657
1.09
0.25
4.2
3.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
38
340
1.12
0.24
1.6
1.9
u/l
33.9
39.6
0.97
33
278
(3011648) Oxygen content in Venous blood
9
77
1.17
0.24
1.6
1.8
%
11.7
10.8
—
9
77
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
81
0.74
0.24
1.0
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
242
2334
1.05
0.24
1.7
1.7
pmol/l
443.1
19630052.2
1.75
202
1890
(3000330) Specific gravity of Urine by Test strip
49
536
0.91
0.23
4.8
3.6
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
39
1.28
0.23
1.8
2.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
135
0.81
0.22
1.4
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
167
0.84
0.21
1.1
1.1
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
11
0.00
0.21
0.0
20.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
54.5
—
0
12
(1761482) Bacteria [#/volume] in Urine by Culture
32
287
1.12
0.21
6.3
4.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
221
2286
0.96
0.21
1.7
1.8
nmol/l
1369.4
1177.1
1.80
164
1716
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
113
0.79
0.20
2.7
4.0
—
—
—
0
0
(3004451) EKG impression Narrative
6
50
1.20
0.19
1.2
1.4
—
—
—
0
0
(4010399)
71
667
1.07
0.18
1.4
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
7
58
1.21
0.18
1.1
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
13
153
0.85
0.18
1.6
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
86
815
1.06
0.18
1.9
2.1
ug/g
106.1
163.8
1.73
66
624
(3024263) Appearance of Synovial fluid
7
61
1.15
0.17
1.4
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
13
110
1.18
0.17
1.8
2.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
63
1.11
0.17
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
167
1.14
0.17
1.4
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
298
0.90
0.16
3.0
3.2
nmol/l
0.8
0.8
0.41
19
227
(3021960) Folate [Moles/volume] in Serum or Plasma
262
2555
1.03
0.16
1.7
1.6
nmol/l
19.2
20.2
0.51
232
2132
(4024509)
11
92
1.20
0.16
1.3
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
91
869
1.05
0.15
1.3
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
90
0.78
0.14
1.1
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
47
441
1.07
0.14
2.2
1.3
g/l
2.4
1.2
0.95
37
398
(3014051) Protein [Presence] in Urine by Test strip
20
222
0.90
0.13
2.5
2.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
278
1.08
0.12
1.2
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
119
1227
0.97
0.11
4.8
4.9
%
31.2
33.1
1.12
83
791
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
86
1.16
0.11
1.2
2.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
45
1.11
0.09
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
415
4198
0.98
0.09
5.3
3.9
ug/l
5.7
2.2
1.31
369
3713
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
196
0.92
0.09
1.5
1.5
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
55
1.09
0.09
1.8
1.7
umol/l
18.2
14.2
—
6
48
(4062490)
5
63
0.79
0.08
1.0
1.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
5
65
0.77
0.08
1.0
1.2
g/l
0.4
0.4
—
5
48
(3028192) IgG subclass 2 [Mass/volume] in Serum
5
65
0.77
0.08
1.0
1.2
g/l
2.9
2.8
—
5
49
(3027135) IgG subclass 1 [Mass/volume] in Serum
5
65
0.77
0.08
1.0
1.2
g/l
7.3
7.2
—
5
49
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
88
1.14
0.08
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
68
1.03
0.08
1.0
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
75
0.80
0.07
4.2
2.2
mmol/l
7.5
7.2
—
6
45
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
84
0.83
0.07
1.7
1.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
24
254
0.94
0.06
3.6
2.7
mmol/l
1.9
1.7
0.43
24
246
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
149
1.07
0.05
1.4
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
309
1.04
0.03
1.3
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
141
1.06
0.03
1.5
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
661
6631
0.99
0.03
6.4
3.7
pmol/l
15.4
15.1
2.97
612
5894
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
54
529
1.02
0.03
2.6
2.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
122
1.07
0.02
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
31
301
1.03
0.02
1.5
1.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
23
238
0.97
0.02
3.7
2.8
mmol/l
7.5
7.6
0.03
23
230
(4306422)
10
93
1.08
0.02
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
28
272
1.03
0.02
1.3
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
133
1338
0.99
0.01
1.3
1.3
iu/ml
19.4
37.9
3.92
39
423
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
106
1.04
0.00
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
174
0.98
0.00
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
158
1.01
0.00
1.1
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
20
199
1.01
0.00
1.5
1.7
—
—
—
0
0
(4094501)
26
255
1.02
0.00
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
15.0
—
0
9
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
374.3
—
0
6
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
76
0.92
0.00
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
60
1.00
0.00
1.5
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
5
57
0.88
0.00
2.0
1.5
mmol/l
8.6
9.5
—
5
43
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
2.0
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
63
0.95
0.00
3.2
3.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
5
56
0.89
0.00
1.0
1.0
—
3.2
—
0
27
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
81
0.99
0.00
1.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
74
0.95
0.00
1.0
2.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
59
1.02
0.00
1.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
54
0.93
0.00
1.0
1.1
mg/l
40.6
36.3
—
5
48
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
49
1.02
0.00
1.0
1.3
nmol/l
119.4
144.7
—
5
49
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
1.4
—
0
5
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RENAL_CELL_CARCINOMA_EXALLC – Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).